Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
[Introduction. Darunavir].
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.
Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.
Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.
Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells.
Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.